Protection for patients with Chronic Atrophic Gastritis (CAG)by immunage June 17, 2015 0 comments
Protection against enzymatic abnormalities of the gastric mucosa for patients with Chronic Atrophic Gastritis (CAG)
Patients with CAG, who are not infected with Helicobacter pylori, show oxidative stress in the gastric mucosa.
Enzymatic abnormalities and oxidative DNA damage in the gastric mucosa caused by this oxidation are associated with pre-cancerous changes which can lead progressively to intestinal carcinoma.
Immun’Âge®/ F.P.P.® helps protect you against enzymatic abnormalities and oxidative damage of the gastric mucosa.
How to take Immun’Âge® and why :
Regular support :
Dosage : 1 to 2 packet(s) / day for 2-3 months, 3-4 times / year.
Action : keeps down-regulating the ongoing oxidative stress and enzymatic abnormalities.
Result : contributes to reducing the ongoing damage and DNA mutations associated with pre-cancerous changes.
In symptomatic phase (fatigue, anorexia, etc.) or overlapping illness :
Dosage : 2-3 packet(s) / day for 4-6 weeks.
Action : helps decrease gastric mucosa oxidation and enzymatic abnormalities.
Result : helps enhance recovery.
The aging/precancerous gastric mucosa: a pilot nutraceutical trial.
Ann. N.Y. Acad. Sci. 1019: 195-199 (2004). © 2004 New York Academy of Sciences.
Doi: 10.1196/annals.1297.031 PMID: 15247013 [PubMed – indexed for MEDLINE]